Tom Murtagh MBA

Joint Global Practice Lead, Strategy & Insight

Tom Murtagh is a seasoned consultant with a wealth of experience in working with leading life science companies since 1995. Throughout his career, he has been instrumental in building and executing growth and leadership strategies across the sector. Tom's expertise spans various areas, from providing product-level strategy support to numerous brand teams in developing effective go-to-market strategies, to offering executive and board-level guidance in designing corporate growth strategies and leading turnarounds.

Drawing on his earlier career in banking and advanced degree work at the University of Chicago, Tom possesses a unique skill set in utilizing quantitative tools and analysis to drive strategic decision-making.

“Too frequently, financial tools, analyses, and metrics are viewed as belonging to the domain of the bankers and financial analysts and are underutilized as inputs to help shape rich strategic decision-making. We seek to infuse our projects with the discipline and insights from finance – as both a way to better understand strategies and their embedded assumptions, as well as a catalyst to help sharpen strategic thinking.”

In recent years, Tom has dedicated much of his efforts to enhancing client decision-making throughout the product development process. Whether providing early guidance to research teams or delivering advanced input to product development teams, Tom thrives on collaborative work with clients to unlock the full potential of groundbreaking science in the pursuit of life-changing therapies. His notable contributions include:

• Input and refinement to product concepts and product profiles for dozens of rare and specialty therapeutic candidates
• Evaluation of numerous pre- and post-POC development-stage candidates for potential in-licensing
• Architecting and implementing a new product decision-making model for a leading rare disease firm
• Development of therapeutic growth strategies for firms in areas as varied as immunology, fibrosis, rare diseases, CNS, and oncology

Prior to Lumanity, Tom was a founder and managing director at Clarion for 20 years. Furthermore, Tom is particularly proud of his commitment to growing and developing industry leaders in the life sciences.

“Our training and development model not only empowers us to excel for our clients but also cultivates future leaders who drive scientific advancements and deliver for patients. It's inspiring to witness our alumni leading and shaping the industry. We take pride in fostering their strategic and organizational skills.”

Tom received an MBA with a concentration in Finance/Marketing from the University of Chicago and a BA from Dartmouth.